Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2300200	注射用重组人脑利钠肽	recombinant human brain natriuretic peptide	Lyophilized	Biological Products(1)	Supplementary Application	2023-10-31		Chengdu Rhodiola Bio-Pharmaceutical Co Ltd			view
CXSS0500032	注射用重组人脑钠素	recombinant human brain natriuretic peptide	Lyophilized	Biological Products	New Drug Application	2005-04-01	苏州苏兰生物医药科技开发有限公司	Suzhou Sulan Biologic Medical Science & Technology Development Co Ltd	Approval Completed-Pending Certificated	2005-05-23	view
CXSL1900064	注射用重组人脑利钠肽	recombinant human brain natriuretic peptide	Lyophilized	Biological Products(10)	New Drug Application	2019-07-05	山东丹红制药有限公司	Shandong Danhong Pharmaceutical Co Ltd	In Review	2019-07-04	view